Prolight Diagnostics AB (publ) (NGM:PRLD)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.3950
-0.0150 (-3.66%)
At close: May 12, 2025
165.10%
Market Cap 277.33M
Revenue (ttm) 36.37M
Net Income (ttm) -26.94M
Shares Out 702.09M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,331,362
Average Volume 2,518,231
Open n/a
Previous Close 0.4100
Day's Range n/a
52-Week Range 0.1170 - 0.8840
Beta 2.84
RSI 41.26
Earnings Date May 16, 2025

About Prolight Diagnostics AB

Prolight Diagnostics AB (publ) develops diagnostic systems used in point of care testing in Sweden. It engages in the development of PLD micro flex and flex membrane. Prolight Diagnostics AB (publ) was incorporated in 1999 and is based in Stockholm, Sweden. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1999
Employees 16
Stock Exchange Nordic Growth Market
Ticker Symbol PRLD
Full Company Profile

Financial Performance

In 2024, Prolight Diagnostics AB's revenue was 36.37 million, an increase of 50.18% compared to the previous year's 24.22 million. Losses were -26.94 million, -80.11% less than in 2023.

Financial Statements

News

There is no news available yet.